Blood Orange and Reduced Prostate Cancer Risk

• Lycopene intake and prostate cancer risk in men at high cardiovascular risk: a prospective cohort study.

  • 2025-11-10
  • RCT · n = 2,970
  • BMC medicine 23(1)
  • • Ricardo López-Solís
    • Sara Castro-Barquero
    • Carolina Donat-Vargas
    • Marina Corrado
    • Camila Arancibia-Riveros
    • Miguel Ángel Martínez-González
    • Jordi Salas-Salvadó
    • Jose V Sorlí
    • Luis Serra-Majem
    • Montserrat Fitó
    • Xavier Pintó
    • Miquel Fiol
    • José Lapetra
    • Enrique Gómez-Gracia
    • Estefanía Toledo
    • Judith B Ramírez-Sabio
    • Nancy Babio
    • Ramón Estruch
    • Emilio Ros
    • Rosa M Lamuela-Raventós

  • PubMed: 41214650
  • DOI: 10.1186/s12916-025-04440-0

  1 Insight on

  • Reduced Prostate Cancer Risk

  • High evidence
  • Large Human Trial
  • Clinical

  Participants in the highest quartile of lycopene intake had a significantly lower risk of prostate cancer than those in the lowest quartile (HR: 0.46; 95% CI: 0.23-0.95; p-trend = 0.035).

  Effect

  Beneficial

  Effect size

  Large

  Significant

  Yes